Cargando…
Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain
For the treatment of neurological diseases, achieving sufficient exposure to the brain parenchyma is a critical determinant of drug efficacy. The blood–brain barrier (BBB) functions to tightly control the passage of substances between the bloodstream and the central nervous system, and as such poses...
Autores principales: | Bajracharya, Rinie, Caruso, Alayna C., Vella, Laura J., Nisbet, Rebecca M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709416/ https://www.ncbi.nlm.nih.gov/pubmed/34959296 http://dx.doi.org/10.3390/pharmaceutics13122014 |
Ejemplares similares
-
Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice
por: Bajracharya, Rinie, et al.
Publicado: (2021) -
Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
por: Teleanu, Raluca Ioana, et al.
Publicado: (2022) -
Current Strategies for Brain Drug Delivery
por: Dong, Xiaowei
Publicado: (2018) -
Ultrasound-mediated blood-brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody
por: Janowicz, Phillip W., et al.
Publicado: (2019) -
Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
por: Parodi, Alessandro, et al.
Publicado: (2019)